Maven Securities LTD Grows Stock Holdings in Alignment Healthcare, Inc. $ALHC

Maven Securities LTD boosted its holdings in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 120.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 110,000 shares of the company’s stock after buying an additional 60,000 shares during the period. Maven Securities LTD’s holdings in Alignment Healthcare were worth $2,172,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of the business. Vanguard Group Inc. grew its stake in Alignment Healthcare by 10.9% in the 4th quarter. Vanguard Group Inc. now owns 15,492,802 shares of the company’s stock valued at $305,983,000 after buying an additional 1,524,218 shares in the last quarter. Wellington Management Group LLP grew its stake in Alignment Healthcare by 167.3% in the 3rd quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company’s stock valued at $193,516,000 after buying an additional 6,940,277 shares in the last quarter. 8 Knots Management LLC grew its stake in Alignment Healthcare by 6.4% in the 2nd quarter. 8 Knots Management LLC now owns 5,015,881 shares of the company’s stock valued at $70,222,000 after buying an additional 300,409 shares in the last quarter. Invesco Ltd. grew its stake in Alignment Healthcare by 7.1% in the 3rd quarter. Invesco Ltd. now owns 4,466,630 shares of the company’s stock valued at $77,943,000 after buying an additional 296,101 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in Alignment Healthcare by 8.4% in the 4th quarter. Geode Capital Management LLC now owns 3,841,703 shares of the company’s stock valued at $75,884,000 after buying an additional 299,279 shares in the last quarter. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Alignment Healthcare

In other news, CEO John E. Kao sold 298,000 shares of Alignment Healthcare stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $20.36, for a total transaction of $6,067,280.00. Following the completion of the sale, the chief executive officer directly owned 1,386,766 shares of the company’s stock, valued at approximately $28,234,555.76. The trade was a 17.69% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Christopher J. Joyce sold 18,013 shares of Alignment Healthcare stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $17.79, for a total transaction of $320,451.27. Following the sale, the insider directly owned 305,451 shares of the company’s stock, valued at $5,433,973.29. This represents a 5.57% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 1,554,685 shares of company stock worth $29,876,743 in the last three months. 5.20% of the stock is owned by insiders.

Alignment Healthcare Price Performance

ALHC opened at $19.75 on Monday. The company has a fifty day moving average price of $18.53 and a 200-day moving average price of $19.41. The firm has a market capitalization of $4.08 billion, a P/E ratio of 219.44, a price-to-earnings-growth ratio of 2.67 and a beta of 1.14. The company has a debt-to-equity ratio of 1.56, a current ratio of 1.58 and a quick ratio of 1.58. Alignment Healthcare, Inc. has a one year low of $11.63 and a one year high of $23.87.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.05 EPS for the quarter, beating analysts’ consensus estimates of $0.01 by $0.04. The firm had revenue of $1.24 billion during the quarter, compared to analyst estimates of $1.22 billion. Alignment Healthcare had a net margin of 0.47% and a return on equity of 11.50%. The business’s revenue for the quarter was up 33.3% on a year-over-year basis. During the same period in the previous year, the business earned ($0.05) EPS. Equities research analysts expect that Alignment Healthcare, Inc. will post 0.2 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on ALHC. Raymond James Financial set a $22.00 price objective on shares of Alignment Healthcare in a research note on Thursday, May 7th. Weiss Ratings upgraded shares of Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Thursday, May 7th. Barclays reduced their price target on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. UBS Group boosted their price target on shares of Alignment Healthcare from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Friday, May 1st. Finally, KeyCorp restated an “overweight” rating on shares of Alignment Healthcare in a research report on Wednesday. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $24.30.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.